Contact UsCenter for Rare Disease Therapies
535 Watson Drive
Claremont, CA 91711 Phone: (909) 607-0120
November 17, 2015
A project that was part of Dr. Ian Phillips' Writing an Orphan Drug Application (ALS 432) class recently led to the U.S. Food and Drug Administration (FDA) awarding KGI an orphan drug designation for Rett syndrome.
October 20, 2015
NIH's Neuro StartUp Challenge Winning Team Receives Orphan Drug Designation.
October 6, 2015
The newly formed Keck Graduate Institute (KGI) Rare Disease Club is helping the National Organization for Rare Disorders (NORD) inspire students at other campuses across the U.S. to establish similar clubs for rare-disease awareness and education.
March 12, 2015
2015 Rare Disease Day at KGI: Precision Medicine for the Treatment of Rare Disease
May 2, 2014
KGI student Courtney Hanlon was one of only three students in the country awarded a 2014 Donald A. King Summer Research Fellowship
March 17, 2014
This year Rare Disease Day at KGI was devoted to an exploration of the issues surrounding the development of new drugs to treat rare diseases. Pricing controversies, the need to get physicians more involved in clinical trial recruitment, and the role of parents as chief advocates and de facto lobbyists were among the topics covered by a roster of highly regarded individual speakers and panelists.
January 31, 2014
This year Rare Disease Day at KGI is dedicated to raising awareness of orphan drugs for rare diseases-something which is greatly needed according to Dr. Ian Phillips, director of KGI's Center for Rare Disease Therapies.
January 13, 2014
Dr. Ian Phillips, director of KGI's Center for Rare Disease Therapies and Norris Professor of Applied Life Sciences, discusses some of the consequences of the Orphan Drug Act of 1983 and the future of orphan drug development on Radio Health Journal.
October 18, 2013
Dr. Ian Phillips, Norris Professor of Applied Life Sciences and director of the Center for Rare Disease Therapies at KGI, spoke to an audience of 500 patient advocates at the Global Genes | RARE Project's 2nd Annual Patient Advocacy Summit in Newport Beach, California.
May 17, 2010
A mother from Reno, Nevada who was a force behind an application for an orphan drug designation has gotten good news: the FDA approved the request.